A. Sharova

Title: Urinary Biomarkers and Attainment of Cefepime Therapeutic Targets in Critically Ill

A. Zuppa, A. Himebauch, K. Downes, 2021 .

Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children’s hospital during coronavirus disease 2019 (COVID-19) pandemic

J. Gerber, S. Hensley, S. Gouma, 2021, Infection Control & Hospital Epidemiology.

Evolution of SARS-CoV-2 Seroprevalence Among Employees of a United States Academic Children's Hospital During the COVID-19 Pandemic.

J. Gerber, S. Hensley, S. Coffin, 2021, Infection control and hospital epidemiology.

Antiviral toxicities in pediatric solid organ transplant recipients

K. Downes, D. Vader, Yun Li, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CMV infection and management among pediatric solid organ transplant recipients

K. Downes, L. Vella, D. Vader, 2022, Pediatric transplantation.

Optimizing Vancomycin Therapy in Critically Ill Children: A Population Pharmacokinetics Study to Inform Vancomycin Area under the Curve Estimation Using Novel Biomarkers

M. Neely, A. Zuppa, K. Downes, 2023, Pharmaceutics.

Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.

F. Lessa, L. Harrison, J. Walston, 2019, Vaccine.